Immunobiology of Influenza Virus Infection: Approaches for an Emerging Zoonotic D
Immunobiology of Influenza Virus Infection: Approaches for an Emerging Zoonotic D
批准号:
7334084
负责人:
RALPH A TRIPP
金额:
$2.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-15 至 2008-05-31
关键词:
AcademiaAnimalsApplied ResearchBasic ScienceCellsDevelopmentEmerging Communicable DiseasesFosteringGenerationsGoalsGovernmentHumanHuman VirusImmuneImmune systemImmunityImmunobiologyImmunologistIndustryInfectionInfluenza A Virus, H5N1 SubtypeMaintenanceMemoryPharmaceutical PreparationsTherapeuticTranslationsVaccine TherapyVaccinesViralViral VaccinesVirusVirus Diseasesinfluenzavirusresponse
中文摘要
大多数新出现的传染病都是由人畜共患病引起的,即
可在人和动物之间传播,导致两个物种的感染。许多人
这些病原体中最危险和最容易传播的是病毒。大多数人
新出现或重新出现的人类病毒缺乏有效的疫苗或抗病毒药物
治疗。最近出现的高致病性禽流感病毒H5N1
强调这一未得到满足的需求。基础和应用研究的最新进展
为了解病毒之间的相互作用提供了一个无与伦比的机会
宿主和免疫系统,特别是在免疫细胞和分子方面
参与免疫的产生、效应机制和所涉及的机制
在免疫记忆反应的产生和维持中起作用。这次会议将
汇集来自学术界、政府和
产业界将基础研究中的新发现有效转化为有效
疫苗和疗法。会议的目标是加快抗病毒疫苗和
治疗发展,以促进对新出现的病毒威胁的快速反应,
会议的焦点是流感病毒。
英文摘要
The majority of emerging infectious diseases are of zoonotic origin, i.e.
transmissible between humans and animals causing infection in both species. Many of the
most dangerous and easily transmitted of these agents are viruses. The majority of the
emerging or re-emerging human viruses lack an effective vaccine or anti-viral drug
treatment. The recent emergence of the highly pathogenic avian influenza virus H5N1
emphasizes this unmet need. Recent advances in basic and applied research have
provided an unparalleled opportunity to understand the interplay between the virus, the
host, and the immune system, particularly on matters of immune cells and molecules
involved in the generation of immunity, effector mechanisms, and mechanisms involved
in the generation and maintenance of immune memory responses. This meeting will
assemble basic and applied viral immunologists from academia, government, and
industry to foster effective translation of new findings in basic research into effective
vaccines and therapies. The goal of the meeting is to accelerate anti-viral vaccine and
therapeutic development, to facilitate a rapid response to the threat of emerging viruses,
with the focus of the meeting centered on influenza viruses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
-
批准号:8636392
-
项目类别:
-
资助金额:$56.38万
-
财政年份:2010
-
负责人:RALPH A TRIPP
-
依托单位:
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
-
批准号:8450155
-
项目类别:
-
资助金额:$52.82万
-
财政年份:2010
-
负责人:RALPH A TRIPP
-
依托单位:
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
-
批准号:7902985
-
项目类别:
-
资助金额:$59.31万
-
财政年份:2010
-
负责人:RALPH A TRIPP
-
依托单位:
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
-
批准号:8051743
-
项目类别:
-
资助金额:$57.32万
-
财政年份:2010
-
负责人:RALPH A TRIPP
-
依托单位:
RSV Nanocapsule Vaccine Engineered with a G Protein Peptide Payload
-
批准号:8247796
-
项目类别:
-
资助金额:$55.79万
-
财政年份:2010
-
负责人:RALPH A TRIPP
-
依托单位:
Antibody inhibition of respiratory syncytial virus G protein activity
-
批准号:7339847
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2007
-
负责人:RALPH A TRIPP
-
依托单位:
Antibody inhibition of respiratory syncytial virus G protein activity
-
批准号:7179193
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2007
-
负责人:RALPH A TRIPP
-
依托单位:
Antibody inhibition of respiratory syncytial virus G protein activity
-
批准号:7744001
-
项目类别:
-
资助金额:$31.75万
-
财政年份:2007
-
负责人:RALPH A TRIPP
-
依托单位:
Antibody inhibition of respiratory syncytial virus G protein activity
-
批准号:7552034
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2007
-
负责人:RALPH A TRIPP
-
依托单位:
MECHANISMS OF CYTOTOXIC T CELL SPECIFICTY TO ADENOVIRUS
-
批准号:3030313
-
项目类别:
-
资助金额:$1.71万
-
财政年份:1992
-
负责人:RALPH A TRIPP
-
依托单位:
MECHANISMS OF CYTOTOXIC T CELL SPECIFICTY TO ADENOVIRUS
-
批准号:3030312
-
项目类别:
-
资助金额:$2.99万
-
财政年份:1991
-
负责人:RALPH A TRIPP
-
依托单位:
MECHANISMS OF CYTOTOXIC T CELL SPECIFICTY TO ADENOVIRUS
-
批准号:3030311
-
项目类别:
-
资助金额:$2.8万
-
财政年份:1991
-
负责人:RALPH A TRIPP
-
依托单位:
海外基金